视神经炎与自身免疫性视神经病:诊断与治疗进展
视神经炎是提示多发性硬化、髓鞘少突胶质细胞糖蛋白抗体相关疾病和视神经脊髓炎谱系疾病等自身免疫性神经疾病的炎性视神经病。早期临床识别有助于判断潜在病因,从而影响预后与治疗。特发性及多发性硬化相关视神经炎患者常能恢复高对比视力,但对比敏感度、双眼视觉和运动感知的残余缺陷可能损害视觉相关生活质量;而髓鞘少突胶质细胞糖蛋白、AQP4和CRMP5抗体血清阳性者的视力恢复可能更差、视神经萎缩更严重。关键临床、影像和实验室发现可鉴别这些疾病,指导诊断检查并优化急性和预防性治疗。基于早期准确诊断视神经炎亚型,及时使用大剂量皮质类固醇以及在某些情况下血浆置换,可能预防高对比视力丧失、改善对比敏感度并保留色觉和视野。
要点
- 视神经炎常提示多发性硬化、MOG抗体相关疾病或视神经脊髓炎谱系疾病等自身免疫性疾病。
- 特发性及多发性硬化相关视神经炎常恢复高对比视力,但对比敏感度、双眼视觉和运动感知可能残留缺陷。
- MOG、AQP4和CRMP5抗体血清阳性者视力恢复可能更差、视神经萎缩更严重。
核心结论
- 早期准确诊断视神经炎亚型,及时使用大剂量皮质类固醇及在某些情况下血浆置换,可能预防高对比视力丧失、改善对比敏感度并保留色觉和视野。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 特发性及多发性硬化相关视神经炎患者常能恢复高对比视力,但对比敏感度、双眼视觉和运动感知的残余缺陷可能损害视觉相关生活质量。
- MOG、AQP4和CRMP5抗体血清阳性者视力恢复可能更差、视神经萎缩更严重。
- 关键临床、影像和实验室发现可鉴别这些疾病,帮助临床医生聚焦诊断检查并优化急性和预防性治疗。
临床怎么用
- 早期准确诊断视神经炎亚型,及时使用大剂量皮质类固醇,在某些情况下可进行血浆置换,以预防高对比视力丧失、改善对比敏感度并保留色觉和视野。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Optic neuritis is an inflammatory optic neuropathy that is commonly indicative of autoimmune neurological disorders including multiple sclerosis, myelin-oligodendrocyte glycoprotein antibody-associated disease, and neuromyelitis optica spectrum disorder. Early clinical recognition of optic neuritis is important in determining the potential aetiology, which has bearing on prognosis and treatment. Regaining high-contrast visual acuity is common in people with idiopathic optic neuritis and multiple sclerosis-associated optic neuritis; however, residual deficits in contrast sensitivity, binocular vision, and motion perception might impair vision-specific quality-of-life metrics. In contrast, recovery of visual acuity can be poorer and optic nerve atrophy more severe in individuals who are seropositive for antibodies to myelin oligodendrocyte glycoprotein, AQP4, and CRMP5 than in individuals with typical optic neuritis from idiopathic or multiple-sclerosis associated optic neuritis. Key clinical, imaging, and laboratory findings differentiate these disorders, allowing clinicians to focus their diagnostic studies and optimise acute and preventive treatments. Guided by early and accurate diagnosis of optic neuritis subtypes, the timely use of high-dose corticosteroids and, in some instances, plasmapheresis could prevent loss of high-contrast vision, improve contrast sensitivity, and preserve colour vision and visual fields. Advancements in our knowledge, diagnosis, and treatment of optic neuritis will ultimately improve our understanding of autoimmune neurological disorders, improve clinical trial design, and spearhead therapeutic innovation.
引用
- Bennett JL, Costello F, Chen JJ, et al. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment. Lancet Neurol. 2022. PMID: 36155661. doi:10.1016/S1474-4422(22)00187-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。